Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Apr;84(7):892–896. doi: 10.1054/bjoc.2000.1701

Chromosomal radiosensitivity as a marker of predisposition to common cancers?

K Baria 1, C Warren 1, S A Roberts 2, C M West 3, D Scott 1
PMCID: PMC2363837  PMID: 11286467

Abstract

We previously found that 40% of breast cancer patients showed enhanced sensitivity to X-ray induced chromosome damage in G 2 lymphocytes and suggested that this might indicate a low penetrance predisposition to breast cancer, for which there is good epidemiological evidence. We have now tested the hypothesis that elevated G 2 radiosensitivity is a marker of such predisposition to other common cancers. We tested patients with colorectal cancer, for which there is also good epidemiological evidence of inherited risk in a substantial proportion of cases, and patients with cancers having a strong environmental aetiology (lung and cervix). We also repeated our study of breast cancer cases and tested patients with chronic diseases other than cancer. The results support our hypothesis, in that 30% (12/37) of colorectal cases showed enhanced sensitivity compared with 9% (6/66) of normal healthy controls (P = 0.01), whereas the proportions of sensitive cervix (11%, 3/27, P = 0.72) and lung cancer cases (23%, 8/35, P = 0.07) were not significantly above normals. We confirmed the enhanced sensitivity of 40% (12/31, P = 0.001) of breast cancer patients and found that patients with non-malignant disease had a normal response in the assay (12%, 4/34, P = 0.73). We suggest that enhanced G 2 chromosomal radiosensitivity is a consequence of inherited defects in the ability of cells to process DNA damage from endogenous or exogenous sources, of a type that is mimicked by ionizing radiation, and that such defects predispose to breast and colorectal cancer. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: radiosensitivity, chromosome aberrations, inherited predisposition, colorectal cancer, lung cancer, cervical cancer

Full Text

The Full Text of this article is available as a PDF (117.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cannon-Albright L. A., Skolnick M. H., Bishop D. T., Lee R. G., Burt R. W. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med. 1988 Sep 1;319(9):533–537. doi: 10.1056/NEJM198809013190902. [DOI] [PubMed] [Google Scholar]
  2. Catalona W. J., Sample W. F., Chretien P. B. Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage. Cancer. 1973 Jan;31(1):65–71. doi: 10.1002/1097-0142(197301)31:1<65::aid-cncr2820310109>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  3. Ford D., Easton D. F., Stratton M., Narod S., Goldgar D., Devilee P., Bishop D. T., Weber B., Lenoir G., Chang-Claude J. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998 Mar;62(3):676–689. doi: 10.1086/301749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Han T., Takita H. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin. Cancer. 1972 Sep;30(3):616–620. doi: 10.1002/1097-0142(197209)30:3<616::aid-cncr2820300304>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  5. Hsu T. C., Johnston D. A., Cherry L. M., Ramkissoon D., Schantz S. P., Jessup J. M., Winn R. J., Shirley L., Furlong C. Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer. 1989 Mar 15;43(3):403–409. doi: 10.1002/ijc.2910430310. [DOI] [PubMed] [Google Scholar]
  6. Levi F. Cancer prevention: epidemiology and perspectives. Eur J Cancer. 1999 Jul;35(7):1046–1058. doi: 10.1016/s0959-8049(99)00094-5. [DOI] [PubMed] [Google Scholar]
  7. Lichtenstein P., Holm N. V., Verkasalo P. K., Iliadou A., Kaprio J., Koskenvuo M., Pukkala E., Skytthe A., Hemminki K. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000 Jul 13;343(2):78–85. doi: 10.1056/NEJM200007133430201. [DOI] [PubMed] [Google Scholar]
  8. Parshad R., Price F. M., Bohr V. A., Cowans K. H., Zujewski J. A., Sanford K. K. Deficient DNA repair capacity, a predisposing factor in breast cancer. Br J Cancer. 1996 Jul;74(1):1–5. doi: 10.1038/bjc.1996.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Patel R. K., Trivedi A. H., Arora D. C., Bhatavdekar J. M., Patel D. D. DNA repair proficiency in breast cancer patients and their first-degree relatives. Int J Cancer. 1997 Sep 26;73(1):20–24. doi: 10.1002/(sici)1097-0215(19970926)73:1<20::aid-ijc4>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  10. Peto J., Mack T. M. High constant incidence in twins and other relatives of women with breast cancer. Nat Genet. 2000 Dec;26(4):411–414. doi: 10.1038/82533. [DOI] [PubMed] [Google Scholar]
  11. Roberts S. A., Spreadborough A. R., Bulman B., Barber J. B., Evans D. G., Scott D. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet. 1999 Sep;65(3):784–794. doi: 10.1086/302544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rüdiger H. W., Schwartz U., Serrand E., Stief M., Krause T., Nowak D., Doerjer G., Lehnert G. Reduced O6-methylguanine repair in fibroblast cultures from patients with lung cancer. Cancer Res. 1989 Oct 15;49(20):5623–5626. [PubMed] [Google Scholar]
  13. Sanford K. K., Parshad R., Gantt R., Tarone R. E., Jones G. M., Price F. M. Factors affecting and significance of G2 chromatin radiosensitivity in predisposition to cancer. Int J Radiat Biol. 1989 Jun;55(6):963–981. doi: 10.1080/09553008914551001. [DOI] [PubMed] [Google Scholar]
  14. Scott D., Barber J. B., Levine E. L., Burrill W., Roberts S. A. Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? Br J Cancer. 1998 Feb;77(4):614–620. doi: 10.1038/bjc.1998.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Scott D., Barber J. B., Spreadborough A. R., Burrill W., Roberts S. A. Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol. 1999 Jan;75(1):1–10. doi: 10.1080/095530099140744. [DOI] [PubMed] [Google Scholar]
  16. Scott D., Spreadborough A., Levine E., Roberts S. A. Genetic predisposition in breast cancer. Lancet. 1994 Nov 19;344(8934):1444–1444. doi: 10.1016/s0140-6736(94)90615-7. [DOI] [PubMed] [Google Scholar]
  17. Teare M. D., Wallace S. A., Harris M., Howell A., Birch J. M. Cancer experience in the relatives of an unselected series of breast cancer patients. Br J Cancer. 1994 Jul;70(1):102–111. doi: 10.1038/bjc.1994.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Terzoudi G. I., Jung T., Hain J., Vrouvas J., Margaritis K., Donta-Bakoyianni C., Makropoulos V., Angelakis P., Pantelias G. E. Increased G2 chromosomal radiosensitivity in cancer patients: the role of cdk1/cyclin-B activity level in the mechanisms involved. Int J Radiat Biol. 2000 May;76(5):607–615. doi: 10.1080/095530000138268. [DOI] [PubMed] [Google Scholar]
  19. Uematsu F., Kikuchi H., Motomiya M., Abe T., Sagami I., Ohmachi T., Wakui A., Kanamaru R., Watanabe M. Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn J Cancer Res. 1991 Mar;82(3):254–256. doi: 10.1111/j.1349-7006.1991.tb01838.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES